Eton Pharmaceuticals (NASDAQ:ETON) -6% announces public offering to sell common shares.
Closing date is October 14, 2020.
Net proceeds will be used primarily for general corporate purposes, which may include research and development activities, capital expenditures, selling, general and administrative costs, and to meet working capital needs.
Price, volume and terms have yet to be determined.
Source: Press Release